Acambis in partnership with sanofi-aventis co for Japanese Encephalitis vaccine |
|
|
|
Published
:
Wed, 14 Feb 2007 09:08
|
LONDON (AFX) - Acambis PLC said it has entered a partnership agreement with sanofi pasteur, thevaccines business of the sanofi-aventis Group, for ChimeriVax-JE, Acambis' single-dose vaccine against Japanese encephalitis (JE).Under the agreement, Acambis has granted sanofi pasteur marketing, distribution and certain manufacturing rights to ChimeriVax-JE worldwide, excluding India and the Indian subcontinent where Acambis has an existing agreement with Bharat Biotech International Ltd, and also excluding the US, for which sanofi pasteur has been granted an option.Sanofi pasteur plans to introduce the new vaccine in Europe and throughout the Asia Pacific region, with particular focus on the large endemic countries, including Thailand and China, Acambis said.Acambis will receive royalties on sales and payment for the supply of bulk manufactured ChimeriVax-JE product. It will also receive upfront and milestone payments of up to 30 mln eur following marketing authorisation of ChimeriVax-JE in key endemic countries and in the European Union.newsdesk@afxnews.comslmCOPYRIGHTCopyright AFX News Limited 2006. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited
|
|
|
|
Print this Story
FDA panel supports Sanofi vaccine 